SynBio.Oxford is pleased to present Dr Michael Morrison, Principal Investigator for Biomodifying Technologies at HeLEX, the Centre for Health, Law and Emerging Technologies.

Dr Michael Morrison currently leads the ESRC funded project 'Biomodifying technologies and experimental space’. This project examines three 'gateway technologies’ with wide-ranging applications in medicine and the life sciences; gene editing, induced pluripotent stem cells, and 3D printing of living material.